Augmentation of Risperidone With Valproic Acid
J Clin Psychiatry 1998;59:430-430 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Sir: The response of psychotic symptoms following the addition of valproate to typical antipsychotic medications has shown conflicting results. The combination of risperidone, lithium, and valproate has been reported to be efficacious in patients with bipolar disorder. We report a patient with schizophrenia for whom the addition of valproic acid to treatment with a typical antipsychotic had no effect on psychotic symptomatology but for whom marked improvement occurred when valproic acid was added to risperidone.